申请人:British Biotech Pharmaceuticals Ltd.
公开号:US20030050310A1
公开(公告)日:2003-03-13
Compounds of formula (I) are matrix metalloproteinase inhibitors wherein X represents a carboxylic acid group —COOH, or a hydroxamic acid group —CONHOH;R
2
represents a radical of formula (II): R
3
—(ALK)
m
—(Q)
p
—(ALK)
n
—, and W represents a cyclic amino radical of formula (IIIA) or (IIIB):
1
公式(I)的化合物是基质金属蛋白酶抑制剂,其中X表示羧酸基- COOH或羟肟酸基- CONHOH;R2表示公式(II)的基团:R3-(ALK)m-(Q)p-(ALK)n-,W表示公式(IIIA)或(IIIB)的环状氨基基团:1。